
University of Oxford
Description
The University of Oxford, while not a direct venture capital firm in the traditional sense, plays a pivotal role in the startup ecosystem through its close association with Oxford Science Enterprises (OSE). OSE, formerly Oxford Sciences Innovation (OSI), was established in partnership with the University to commercialize its world-leading research by investing in spin-out companies. This unique model allows the University's groundbreaking discoveries in areas like life sciences, deep technology, and artificial intelligence to transition from academic labs into viable commercial ventures. OSE acts as a dedicated investment partner, providing crucial capital and strategic support to these nascent companies.
OSE's financial backing is substantial, underscoring its commitment to fostering innovation. In July 2022, the firm announced a significant fundraise of £250 million, which brought its total capital raised to over £850 million. This considerable financial capacity enables OSE to support companies from their earliest stages through to significant growth. The firm's investment strategy is characterized by providing "patient capital," meaning it is prepared to invest over longer time horizons, recognizing the often-extended development cycles inherent in deep tech and life science ventures.
To date, Oxford Science Enterprises has made investments in more than 80 companies, which collectively have attracted over £2 billion in external capital from a diverse range of global investors. OSE typically invests across various stages, from seed to Series B and beyond. For initial investments, the firm's typical first cheque sizes range from approximately £1 million to £5 million. This early-stage funding is critical for validating technologies, building initial teams, and achieving key milestones necessary for subsequent larger funding rounds. OSE's model is instrumental in bridging the gap between academic research and commercial success, solidifying Oxford's position as a hub for scientific and technological innovation.
Investor Profile
University of Oxford has backed more than 28 startups, with 4 new investments in the last 12 months alone. The firm has led 1 rounds, about 4% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Seed rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Typical check size: $1.3M – $6.3M.
Stage Focus
- Series A (39%)
- Series Unknown (21%)
- Seed (18%)
- Series B (18%)
- Series D (4%)
Country Focus
- United Kingdom (96%)
- United States (4%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Information Technology
- Therapeutics
- Software
- Life Science
- Chemical
- Location Based Services
- Mobile Apps
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.